Episode 127: Reduce and Manage Extravasations When Administering Cancer Treatments

ONS member MiKaela Olsen, DNP, APRN-CNS, AOCNS^®, FAAN, clinical nurse specialist in the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital and Greenspring Oncology in Baltimore, MD, and member of the Mid-Chesapeake Bay ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss extravasation of antineoplastic agents used in cancer care and what oncology nurses need to know about administering vesicant chemotherapy. Olsen was the lead editor of the ONS Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice. 

Episode Notes 

Check out these resources from today’s episode: 

• The NCPD activity for this episode has expired, but you can still earn NCPD through many other Oncology Nursing Podcast episodes. Find a full list of opportunities.

• Oncology Nursing Podcast Episode 92: Doxorubicin: The Infamous Red Devil 

• Oncology Nursing Podcast Episode 121: Home Infusion of Antineoplastics During COVID-19 

• ONS Voice article: The Case of the Vexing Vesicant 

• Access Device Standards of Practice for Oncology Nursing 

• ASCO/ONS Chemotherapy Administration Safety Standards 

• ONS Book: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice 

• Clinical Journal of Oncology Nursing article: Chemotherapy Extravasation: Establishing a National Benchmark for Incidence Among Cancer Centers 

• Clinical Journal of Oncology Nursing article: Venous Flare Reactions: A Case Report of Reactions Following Etoposide Infusion 

• ONS/ONCC Chemotherapy Immunotherapy Certificate Course 

To discuss the information in this episode with other oncology nurses, visit the ONS Communities.

To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.

Listen on:

Listen on Amazon Music, Listen on Apple Podcasts, Listen on Spotify, Listen on YouTube Music